Efficacy and Safety of Tralokinumab Plus Concomitant Topical Corticosteroids (TCS) in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 6, p. s102, 2020. DOI: 10.25251/skin.4.supp.102. Disponível em: https://skin.dermsquared.com/skin/article/view/1079. Acesso em: 7 nov. 2025.